Article thumbnail

Low bone mineral density in men with chronic obstructive pulmonary disease

By James M Duckers, Bronwen AJ Evans, William D Fraser, Michael D Stone, Charlotte E Bolton and Dennis J Shale
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). A: Use of inhaled corticosteroids and the risk of fracture. Chest
  2. (2005). Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil
  3. (1992). AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax
  4. (2006). Agusti AG: Mortality in COPD: Role of comorbidities.
  5. (2006). Biochemical Markers of Bone Turnover Part II: Clinical Applications in the Management of Osteoporosis. Clin Biochem Rev
  6. (1999). Chronic glucocorticoid therapyinduced osteoporosis in patients with obstructive lung disease. Chest
  7. (2011). Cockcroft JR: Aortic Calcification, Bone Mineral Density and Arterial Stiffness in Patients with COPD.
  8. (2002). COPD and osteoporosis. Chest
  9. (2008). Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm Pharmacol Ther
  10. (2007). DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling.
  11. (1985). E: Inspiratory muscle function in patients with severe kyphoscoliosis. Am Rev Respir Dis
  12. (2010). EOLO study group: Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int
  13. (1993). Fitzpatrick LA: Noninvasive testing in the diagnosis of osteomalacia.
  14. (2006). High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc
  15. (2003). Hurd SS: Global Strategy for the Diagnosis, Management and Prevention of COPD:
  16. (2008). Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf
  17. (2004). KB: Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
  18. (2001). KH: Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia.
  19. (2001). L: Bone markers: Biochemical and Clinical Perspectives.
  20. (2007). Lasserson TJ: Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev
  21. (1987). MA: Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax
  22. (1997). Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet
  23. (1999). MS: Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest
  24. (1984). Organisation: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
  25. (1996). PD: Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
  26. (2004). Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study.
  27. (2008). Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest
  28. (1990). Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis
  29. (2011). Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax
  30. (2007). Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
  31. (2010). Sciurba FC: Plasma inflammatory mediators associated with bone metabolism in COPD. COPD
  32. (2011). Sciurba FC: Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort. Am J Respir Crit Care Med
  33. (2007). Shale DJ: Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med
  34. (2004). Shale DJ: Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med
  35. (1991). SP: Hip fractures among the elderly: factors associated with in-hospital mortality.
  36. (2004). Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J
  37. (1983). Steroid-induced fractures and bone loss in patients with asthma.
  38. (2011). TA: Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int
  39. (2007). V: The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med